Sermorelin-GHRP 2, A Profound Effect on Body Composition with Renewed Energy!

Sermorelin-GHRP 2, A Profound Effect on Body Composition with Renewed Energy!

SERMORELIN-GHRP 2 & GHRP 6

Call Core Medical Group to learn more about our FDA approved. It is the Second Generation HGH releasing peptide therapy.

We are the Nation’s foremost medical experts in HGH optimization through the use of prescription Sermorelin GHRP2 & GHRP6! Importantly, we are also the only Men’s Hormone Clinic that requires our pharmacies to send out Laboratory Analysis Reports with every Rx to every patient.

Far superior technology than any other Sermorelin product available in the US. See the difference with BTP.

  1. Increase Energy
  2. Eliminate Cellulite
  3. Increase Mood and Memory
  4. Increase Lean Muscle Mass
  5. Reduce Body Fat
  6. Improve Skin Tone
  7. Lower Blood Pressure
  8. Improve Cholesterol levels
  9. Improve Kidney Function

At Core Medical Group, our state-of-the-art compounding pharmacy focuses their considerable knowledge on an important thing. It produces a product that delivers greater benefits to the patient at a price that is more affordable than HGH. This exciting, new product, SERMORELIN GHRP2, has proven to be much more effective. Additionally, It has a more profound effect on body composition.

When we’re young, our bodies produce a growth hormone releasing factor. That triggers our pituitary gland to produce and release human growth hormone (hGH). They come in levels that are sufficient to sustain good health and vitality. However, as we age, growth hormone releasing factor declines. It causes a decrease in the production and secretion of pituitary hGH. This often results in a growth hormone deficiency. That can erode health, diminish vigor and vitality, and lead to a host of undesirable symptoms.

A Natural, Effective, Affordable Alternative

Traditionally, adult growth hormone deficiency (AGHD) has been treated by substituting natural hGH with recombinant human growth hormone (rhGH). However, now our breakthrough product, SERMORELIN GHRP2, offers a natural, effective, and affordable alternative to recombinant human growth hormone for those suffering from the symptoms of age-related growth hormone deficiency.

Developed in 1998 by Serono Laboratories, Inc., the makers of Saizen hGH, FDA approved Sermorelin is the most natural and effective treatment for AGHD. Furthermore, as a releasing agent, SERMORELIN GHRP2 triggers the pituitary gland to produce your own natural growth hormone. Consequently, your body regulates the level and frequency of hGH release, ensuring that you don’t experience the side effects associated with injected rhGH.

No Off Cycles!

SERMORELIN GHRP2 requires no off-cycles. In fact, the longer you use it, the better your pituitary gland functions, resembling its performance when you were younger. Additionally, SERMORELIN GHRP2 can be used to re-stimulate the natural production of human growth hormone. This makes it a highly effective off-cycle medication for those undergoing an injected rhGH therapy program.

At our pharmacy, we’ve combined the pituitary-supporting effects of Sermorelin with the stimulating action of GHRP-2 (Growth Hormone Releasing Peptide). By using GHRP-2, we stimulate the pituitary gland, causing an increase in growth hormone release. Moreover, GHRP-2 not only amplifies your GH releasing hormone but also suppresses other hormones that inhibit your body’s natural growth hormone secretion. Additionally, GHRP-2 supports your central nervous system by protecting neurons and enhancing strength, similar to certain steroids in the dihydrotestosterone family.

Restore Your Health and Vitality!

Bottom line, restoring optimal growth hormone levels can sustain and promote youthful anatomy and physiology. As a result, it helps to restore the health and vitality often lost with age-related growth hormone deficiency. Furthermore, SERMORELIN GHRP2 not only provides the youth-restoring benefits of HGH on body composition, but it also helps maintain good pituitary health.

Post by admin

Comments are closed.